PG851: GLM--ANOVA

This blog is for the use of students enrolled in either section of PG851. It is intended to be a forum for asking, discussing, clarifying, and helping.

Wednesday, January 09, 2008

Stacy Amano's Recommendations

Asthana, S., Craft, S., Baker, L. D., Raskind, M, Birnbaum, R. S., Lofgreen, C. P., et al. (1999). Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology, 24, 657-677.
Buckwalter, J. G., Crooks, V. C., Robins, S. B., & Petitti, D. B. (2004). Hormone use and cognitive performance in women of advanced age. Journal of the American Geriatric Society, 52, 182-186.
Carlson, M. C., Zandi, P. P., Plassman, B. L., Tschanz, J. T., Welsh-Bohmer, K. A., Steffens, D., et al. (2001). Hormone replacement therapy and reduced cognitive decline in older women. The Cache County Study. Neurology, 57, 2210-2216.
Dunkin, J. D., Rasgon, N., Wagner-Steh, K., David, S., Altshuler, L., & Rapkin, A. (2005). Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women. Psychoneuroendocrinology, 30, 284-296.
Hogervost, E., Williams, J., Budge, M., Riedel, W., & Jolles, J. (2000) The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience, 101, 485-512.
Henderson, V. W., Paganini-Hill, A., Miller. B. L., Elble, R. J., Reyes, P. F., Shoupe, D. et al. (2000). Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebo-controlled trial. Neurology, 54, 295-301.
Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A. et al., (1997). A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology, 48, 1517-1521.
Mulnard, R. A., Cotman, C. W., Kawas, C., van Dyck, C. H., Sano, M., Doody, R. et al. (2000). Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Journal of the American Medical Association, 283, 1007-1015.
Resnick, S. M., Metter, E. J., & Zonderman, A. B. (1997). Estrogen replacement decline in visual memory. A possible protective effect? Neurology, 49, 1491-1497.
Sherwin, B. B. (1997). Estrogen effects on cognition in menopausal women. Neurology, 48 (Suppl 7), S21-S26.
Tang, M. X., Jacobs, D., & Stern, Y. (1996). Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet, 348, 429-432.
Wang, P. N., Liao, S. Q., Liu, R. S., Liu, C. Y., Chao, H. T., Lu, S. R., et al. (2000). Effects of estrogen on cognition, mood and cerebral blood flow in AD: a controlled study. Neurology, 54, 2061-2066.
For literature regarding other current projects, please come by my office.

0 Comments:

Post a Comment

<< Home